Skip to main content
Ronald Go, MD, Oncology, Rochester, MN, Mayo Clinic Hospital - Rochester

RonaldSGoMD

Oncology Rochester, MN

Professor, Internal Medicine, Mayo Med Sch

Dr. Go is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Go's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1993 - 1996
  • University of Santo Tomas
    University of Santo TomasClass of 1991

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1998 - Present
  • MN State Medical License
    MN State Medical License 2010 - 2024
  • IA State Medical License
    IA State Medical License 2010 - 2014
  • WI State Medical License
    WI State Medical License 2000 - 2013
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
    S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
  • Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
    Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
  • Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
    Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
  • Join now to see all

Abstracts/Posters

  • A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
    Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
    Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
    Ronald S. Go, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Long-Term Survivorship with Active Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Prognostic Value of Clone Size in Paroxysmal Nocturnal Hemoglobinuria (PNH) for Thrombotic Events in Untreated Patients in the International PNH Registry 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Expert Care, Teamwork Lead to Tailored Treatment for Alexa’s Rare Cancer
    Expert Care, Teamwork Lead to Tailored Treatment for Alexa’s Rare CancerJanuary 10th, 2020
  • Clinical Challenges: Secondary ITP
    Clinical Challenges: Secondary ITPDecember 5th, 2018
  • The Art and Science of Never Giving Up
    The Art and Science of Never Giving UpMay 5th, 2022

Grant Support

  • Gundersen Lutheran Proposal to Join CCOPNational Cancer Institute2011–2013
  • Determining the clinical significance of MGUSNational Cancer Institute2011–2013

Professional Memberships

Other Languages

  • Taiwanese, Chinese (Mandarin), Tagalog, Spanish

Hospital Affiliations